Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Grants
Publications
Search by expertise, name or affiliation
A Vaccine for Multiple Sclerosis: Is it a Feasible Option?
Dennis N. Bourdette
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A Vaccine for Multiple Sclerosis: Is it a Feasible Option?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Multiple Sclerosis
100%
Vaccines
84%
T-Lymphocytes
70%
Thomsen-Friedenreich antibodies
57%
Autoimmune Experimental Encephalomyelitis
33%
Immunization
23%
Peptides
18%
Myelin Basic Protein
17%
Immune System Diseases
15%
Myelin Sheath
14%
Major Histocompatibility Complex
14%
T-Cell Antigen Receptor
14%
Oral Administration
12%
Vaccination
11%
Animal Models
10%
Antigens
8%
Proteins
5%
Therapeutics
4%